93 related articles for article (PubMed ID: 3324526)
1. Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study.
Kober G; Hopf R; Biamino G; Bubenheimer P; Förster K; Kuck KH; Hanrath P; von Olshausen KE; Schlepper M; Kaltenbach M
Z Kardiol; 1987; 76 Suppl 3():113-8. PubMed ID: 3324526
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
Lösse B; Loogen F; Schulte HD
Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
[TBL] [Abstract][Full Text] [Related]
4. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
Crittin J; Mayor C; Bloch A
Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
[TBL] [Abstract][Full Text] [Related]
5. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
Haberer T; Hess OM; Jenni R; Krayenbühl HP
Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
[TBL] [Abstract][Full Text] [Related]
6. Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.
Hopf R; Kaltenbach M
Z Kardiol; 1987; 76 Suppl 3():105-12. PubMed ID: 3433863
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of hypertrophic cardiomyopathy with nifedipine and propranolol in combination].
Hopf R; Thomas J; Klepzig H; Kaltenbach M
Z Kardiol; 1987 Aug; 76(8):469-78. PubMed ID: 3673167
[TBL] [Abstract][Full Text] [Related]
8. [Medical treatment of hypertrophic myocardiopathy. Comparison of propranolol and verapamil].
Bouhour JB; Potiron M; Chiffoleau S; Lefévre M; Louvet S
Arch Mal Coeur Vaiss; 1987 Jan; 80(1):76-82. PubMed ID: 3107495
[TBL] [Abstract][Full Text] [Related]
9. [Long-term course of hypertrophic cardiomyopathy: drug versus surgical therapy].
Seiler C; Hess OM; Turina J; Schoenbeck M; Jenni R; Rothlin M; Senning A; Turina M; Krayenbühl HP
Schweiz Med Wochenschr; 1989 Oct; 119(43):1511-4. PubMed ID: 2609126
[TBL] [Abstract][Full Text] [Related]
10. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
[No Abstract] [Full Text] [Related]
11. [Importance of current ultrasonic study methods for the diagnosis, follow-up of treatment effectiveness and prognosis of patients with hypertrophic obstructive cardiomyopathy].
Pal L; Fedorova IF; Schäfer R; Sergakova LM; Naumov VG
Ter Arkh; 1987; 59(10):90-4. PubMed ID: 3433228
[TBL] [Abstract][Full Text] [Related]
12. [Long-term therapy of hypertrophic obstructive and non-obstructive cardiomyopathy with nifedipine in comparison to propranolol].
Cserhalmi L; Assmann I; Glavanov M; Rev J; Kelecseńeyi Z
Z Gesamte Inn Med; 1984 Jul; 39(14):330-5. PubMed ID: 6435321
[TBL] [Abstract][Full Text] [Related]
13. [Outcome of hypertrophic and obstructive myocardiopathies treated with high doses of propranolol].
Bourmayan C; Dussaule JC; Artigou JY; Fournier C; Fernandez F; Desnos M; Gerbaux A; Gay J
Arch Mal Coeur Vaiss; 1985 Sep; 78(9):1409-16. PubMed ID: 3936444
[TBL] [Abstract][Full Text] [Related]
14. Use of verapamil in the treatment of hypertrophic cardiomyopathy.
Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
Cor Vasa; 1986; 28(6):404-12. PubMed ID: 3829686
[TBL] [Abstract][Full Text] [Related]
15. [Conservative medical treatment of hypertrophic myocardiopathies].
Kaltenbach M; Hopf R
Z Kardiol; 1982 Dec; 71(12):795-805. PubMed ID: 6891871
[TBL] [Abstract][Full Text] [Related]
16. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.
Sherrid MV; Barac I; McKenna WJ; Elliott PM; Dickie S; Chojnowska L; Casey S; Maron BJ
J Am Coll Cardiol; 2005 Apr; 45(8):1251-8. PubMed ID: 15837258
[TBL] [Abstract][Full Text] [Related]
17. [Clinical aspects, course and prognosis of various forms of hypertrophic cardiomyopathy].
Kuhn H; Gietzen F; Mercier J; Lösse B; Köhler E; Schulte HD; Bircks W; Loogen F
Z Kardiol; 1983 Feb; 72(2):83-98. PubMed ID: 6221476
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
Lösse B; Kuhn H; Loogen F
Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
[No Abstract] [Full Text] [Related]
19. [Hypertrophic cardiomyopathy in childhood: studies of the clinical picture and course].
Schmaltz AA; Sieverding L; Barth H; Steil E; Apitz J
Z Kardiol; 1986 Jul; 75(7):435-40. PubMed ID: 3765768
[TBL] [Abstract][Full Text] [Related]
20. [Effect of long-term treatment with verapamil on the clinical picture and exertion tolerance in patients with hypertrophic cardiomyopathy].
Nowalany-Kozielska E; Wodniecki J; Tendera M; Poloński L
Kardiol Pol; 1987; 30(7):409-18. PubMed ID: 3316787
[No Abstract] [Full Text] [Related]
[Next] [New Search]
